Six years after the onset of the COVID-19 pandemic, long COVID continues to disrupt the employment of about one in five workers in OECD countries, potentially costing between β¬58.54 billion and β¬115.3 billion annually over the next decade, while also imposing significant healthcare costs and contributing to broader economic losses as individuals cope with various chronic conditions linked to the virus. #LongCOVID #EconomicImpact #HealthSystem
A nationwide study in Denmark found no association between the use of Tylenol during pregnancy and autism in children, revealing that autism was diagnosed in 1.8% of children exposed to the drug compared to 3% of those unexposed, with similar findings echoed in a 2024 Swedish study, despite a 2025 review suggesting a potential link to neurodevelopmental disorders. #Pregnancy #Autism #Healthcare
An international investigation reveals that Merck's commercial strategy for its cancer drug Keytruda, which costs over R$20,000 in Brazil, employs complex legal and pricing tactics to control access, thereby making it increasingly inaccessible to many patients worldwide, despite its significant role in treating various cancers and generating billions in revenue. #CancerTreatment #PharmaceuticalIndustry #HealthInequality
Six years post-COVID-19 pandemic, long COVID continues to disrupt the employment of about one in five workers, potentially costing OECD countries between β¬58.54 billion and β¬115.3 billion annually and imposing significant long-term pressures on health systems and national economies, with considerable implications for workforce productivity and broader socioeconomic stability. #LongCOVID #EconomicImpact #HealthCare
#RedMeat #DiabetesRisk #HealthyEating
#BreastCancer #HealthAwareness #CancerSurvivor
#AI #Biotechnology #Healthcare
#Alzheimers #HealthInnovation #EarlyDiagnosis
#HipFlexors #Posture #HealthAwareness
#ColorectalCancer #HealthAwareness #CancerScreening
#HeartHealth #HealthyEating #BreakfastChoices
